GlassScriptPhysician profile
Michael Charles Smith
NPI 1306178538
$20,188.50
in general payments reported to CMS, 2019-2025
22 companies · $4,967 in 2025
The $4,967 reported for 2025 was more than what 90% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12K · 2020: $140 · 2021: $594 · 2022: $1,397 · 2023: $242 · 2024: $450 · 2025: $4,967.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,722 · Food and Beverage: $937.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,722.39 |
| Food and Beverage | $937.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $17,587.80 | 2019-2025 | Da Vinci Surgical System |
| Medical Device Business Services, INC. | $1,270.43 | 2019 | |
| Lexington Medical, INC. | $274.79 | 2024 | Aeon Endostapler & Echelon Flex Powered Stapler |
| Pacira Pharmaceuticals Incorporated | $180.98 | 2024-2025 | Exparel |
| Integra Lifesciences Corporation | $125.70 | 2021-2024 | Integra, Integra Dermal Regeneration Template, Omnigraft |
| Depuy Synthes Sales INC. | $112.75 | 2019 | |
| Cook Medical LLC | $86.33 | 2019 | |
| Tela Bio, INC. | $76.61 | 2023-2024 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Takeda Pharmaceuticals U.S.A., INC. | $59.38 | 2023-2024 | Gattex |
| Davol INC. | $57.88 | 2019 | |
| Stryker Corporation | $56.14 | 2023 | Spy-Phi System |
| Innocoll Pharmaceuticals Limited | $47.78 | 2021-2022 | |
| Jazz Pharmaceuticals INC. | $45.39 | 2023-2024 | |
| Ethicon US, LLC | $40.94 | 2025 | Echelon Circular |
| Smith+Nephew, INC. | $31.20 | 2019-2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $25.63 | 2025 | |
| Polynovo North America LLC | $25.11 | 2025 | Novosorb Btm |
| Hologic INC | $24.99 | 2022 | |
| Acell, INC. | $19.06 | 2019 | |
| Tactile Systems Technology INC | $16.28 | 2024 | Entre Plus, Flexitouch Plus |
| Medtronic, INC. | $12.41 | 2021 | |
| Kci USA, INC. | $10.92 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.